The Pathogenesis of Depression - Possible Autoimmune Mechanisms

Last updated: March 23, 2022
Sponsor: HaEmek Medical Center, Israel
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Connective Tissue Diseases

Collagen Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT05293899
143-19EMC
  • Ages > 18
  • All Genders

Study Summary

It has long been claimed that depression, and other psychiatric illness, might be a manifestation of immune dysregulation involving the Central nervous system. Depression is associated with a significantly increased risk of autoimmune disease compared to those without a history of depression. The increased risk of autoimmune diseases is during the first year following the onset of depression .Conversely, up to 50% of patients with autoimmune diseases show an impairment of health-related quality of life and exhibit depressive symptoms.

The aggregation of depression and some specific autoimmune diseases may demonstrate shared inherited pathogenesis.

The first phase of the study will include patients with the diagnosis of depression. The control group will consist of a healthy population, according to medical records and will be recruited through a recruitment ad and volunteers. In the second phase of the study first and second-degree relatives (parents, siblings, children, grandparents, aunts, uncles and cousins) who are diagnosed with autoimmune disease/s will be recruited. Auto-immune diseases will include - Rheumatoid Arthritis (RA), juvenile idiopathic arthritis JIA), Seronegative spondyloarthropathies (SPA) including inflammatory bowel disease (IBD), psoriatic arthritis (PsA), and ankylosing spondylitis. Other autoimmune diseases: Systemic Lupus Erythematosus, Sjogren' syndrome (SS), systemic sclerosis (SSc), inflammatory myopathies (IIM), any Overlap of the above including mixed connective tissue disease (MCTD), systemic vasculitis (see Chapel Hill classification criteria). All autoimmune diseases will be confirmed by an expert rheumatologist or an internist. Celiac disease, Diabetes Mellitus type I, autoimmune thyroiditis, autoimmune hepatitis will be confirmed by a gastroenterologist, endocrinologist or an internist.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients must meet DSM-5 (Diagnostic and Statistical Manual of Mental Disorders)criteria for a diagnosis of depression.
  • Sufficient knowledge of the Hebrew language
  • A stabled mental state. If hospitalized, patients are scheduled for discharge based onclinical assessment of psychiatric symptoms.

Exclusion

Exclusion Criteria:

  • Mental co-morbidity.

Study Design

Total Participants: 200
Study Start date:
February 15, 2022
Estimated Completion Date:
April 15, 2026

Connect with a study center

  • Haemek medical center

    Afula, 1910500
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.